发明名称 NOVEL ETHYLENEDIAMINE DERIVATIVES.
摘要 <p>A compound represented by the following general formula (1): Q1-Q2 -T0- N(R1)- Q3- N(R2)- T1-Q4 (1) wherein R1 and R2 represent each hydrogen, etc.; Q1 represents optionally substituted and saturated or unsaturated 5- to 6-membered cyclic hydrocarbyl, etc.; Q2 represents a single bond, etc.; Q3 represents a group -C(R3a) (R4a)- {C(R3b) (R4bm1 -{C(R3c) (R4c m2- {C(R3d) (R4d m3- {C(R3e) (R4em4 -C(R3f) (R4f)- (wherein R3a to R4e represent each hydrogen, etc.); T0 represents carbonyl, etc.; and T1 represents -COCONR-, etc.; its salt, solvates thereof or N-oxides of the same. These compounds are useful as preventives and/or remedies for cerebral infarction, cerebral embolism, myocardial infarction, angina, pulmonary infarction, pulmonary embolism, Buerger disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombosis after artificial valve/joint replacement, thrombosis and reocclusion after reconstructing blood circulation, systemic inflammatory response syndrome (SIRS), multiorgan dysfunction syndrome (MODS), thrombosis in extracorporeal circulation and blood coagulation in blood collection.</p>
申请公布号 MXPA05007012(A) 申请公布日期 2005.08.18
申请号 MX2005PA07012 申请日期 2003.12.24
申请人 DAIICHI PHARMACEUTICAL CO., LTD. 发明人 SUZUKI, MAKOTO
分类号 A61P7/02;A61P9/00;A61P9/04;A61P9/10;A61P43/00;C07D213/75;(IPC1-7):A61K31/437;C07D237/20;C07D401/04;C07D401/14;C07D413/12;C07D471/04;C07D513/04;A61K31/443;A61K31/55;A61K31/541;A61K31/537;A61K31/50;A61K31/496;A61K31/454;A61K31/444 主分类号 A61P7/02
代理机构 代理人
主权项
地址